PSP Faculty Research Interests:
Nilanjana Dwibedi, MBA, PhD: Dr. Dwibedi’s research interests include assessment of patient-reported outcomes measures, medication error prevention, evaluating medication adherence, applying new methodology to conduct pharmacoepidemiology research and evaluating the impact of new technology in US healthcare systems.
Khalid M. Kamal, MPharm, PhD:
Dr. Kamal's primary research and teaching interests have been pharmacoeconomics, patient- reported outcomes research, research methods, and improving quality of care using real-world data sources such as electronic medical records and specialty pharmacy data. Over the years, his research has focused on issues such as cost-effectiveness of treatments, quality of life, productivity costs, economic burden of diseases, and issues related to quality of care in chronic (rheumatoid arthritis, multiple sclerosis, diabetes) and rare conditions (cystic fibrosis).
Dr. Kamal's scholarship has yielded over 60 peer-reviewed publications and two research-based book chapters. He has also disseminated his work via 125 research presentations at national and international meetings. Among his awards are the 2010 Duquesne University School of Pharmacy Faculty award for outstanding contributions in teaching, research, and service; top poster award at the 2015 Annual Meeting & Expo of National Association of Specialty Pharmacy; second prize in the student research presentation category at the 2014 annual meeting of Drug Information Association (DIA); best paper award at the 2010 annual meeting of the Academy of Managed Care Pharmacy (AMCP) and the 2006 Association of Rheumatology Health Professionals Graduate Student Award.
Prior to joining West Virginia University, Dr. Kamal was on the faculty of Duquesne University School of Pharmacy for 15 years. He has been a Visiting Professor teaching pharmacoeconomics and decision modeling courses at institutions such as Kobe Gakuin University in Kobe, Japan and King Saud University in Riyadh, Saudi Arabia. Dr. Kamal has also been involved in international faculty and student exchange programs in Japan, India, and Saudi Arabia.
Dr. Kamal serves as the Chair (2019-2021) of the Faculty Advisory Council within the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). The charge of the Council is to support ISPOR student members' professional development by providing learning experiences, networking opportunities, and continuity to the student chapters. He also serves on ISPOR’s Health Science Policy Council, which advises the Society on key scientific research and research policy issues in health economics outcomes research.
Kimberly Kelly, PhD, MS: Three overlapping themes emerge from Dr. Kelly’s research: (1) cancer risk perception/communication, (2) health behavior (e.g., cancer screening, genetic testing), and (3) elevated risk populations (e.g., Appalachians, those with a family history of cancer). Her work relies on behavioral theory from psychology (health, social, cognitive), as well as communication and information sciences. She mixes qualitative and quantitative methods, utilizing clinic-based and community-based approaches. Most of her research has focused on how risk is communicated in the context of cancer genetic counseling and how risk perceptions differ from objective estimates of risk. She also examines the role of risk perception in cancer screening. Through her research, Dr. Kelly hopes to understand how best to enhance appropriate decision-making about health behaviors in elevated risk populations to accomplish optimal health outcomes.
Traci J. LeMasters, PhD: Dr. LeMasters research interests lie within the fields of pharmacoepidemiology, health services, and outcomes research. Her topics of study have included cancer risk, prevention, treatment patterns, and survival outcomes, including survival analysis and health-related quality of life (HRQoL). Her research has been heavily focused on these issues as they pertain to breast cancer, and more recently, the relationship between mammography screening, guideline recommendations, and the risk for false-positives.
Dr. Virginia G. Scott, RPh, MS, PhD, is a Professor in the Department of Pharmaceutical Systems and Policy and Director of Continuing Education at the West Virginia University School of Pharmacy. She joined the faculty of WVU in 1994 where she teaches courses in Outcomes and Quality Improvement, Patient Health Education, and Pharmacoeconomics.Dr. Scott's focus has been to educate and train students and pharmacists to provide services which will enhance the patient's quality of life. She is a frequent lecturer on medication error reduction, quality improvement, and methods to redesign pharmacies to provide optimal care. She has also worked extensively with the West Virginia Medicaid Program to improve the quality of pharmacy services to the citizens of West Virginia. She has published in peer review journals and given presentations on the local, state, and national levels. Dr. Scott has been and continues to be active in professional pharmacy organizations on the local, state, and national levels.